Trade

with

Laboratory Corp of America Hldgs
(NYSE: LH)
AdChoices
103.73
+1.05
+1.02%
After Hours :
103.73
0.00
0.00%

Open

103.12

Previous Close

102.68

Volume (Avg)

494.73k (535.38k)

Day's Range

102.44-103.89

52Wk Range

87.01-108.77

Market Cap.

8.81B

Dividend Rate ( Yield )

-

Beta

0.66

Shares Outstanding

84.90M

P/E Ratio (EPS)

17.24 (6.01)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 5.81B

    • Net Income

    • 573.80M

    • Market Cap.

    • 8.81B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 9.05

    • PEG (Price/Earnings Growth) Ratio

    • 0.39

    • Beta

    • 0.66

    • Forward P/E

    • 14.37

    • Price/Sales

    • 1.56

    • Price/Book Value

    • 3.32

    • Price/Cash flow

    • 10.45

      • EBITDA

      • 1.24B

      • Return on Capital %

      • 7.70

      • Return on Equity %

      • 19.89

      • Return on Assets %

      • 7.70

      • Book Value/Share

      • 31.29

      • Shares Outstanding

      • 84.90M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.20 (3/29/1994)

      • Dividend Declaration Date

      • 3/11/1994

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 108.67

        • Credit Rating

        • BBB+

        • Analysts

        • 8

        • EPS Estimate

        • 6.82

        • Cashflow Estimate

        • 10.35

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.30

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -1.60

          • -5.55

          • Net Income

            Q/Q (last year)

          • -7.00

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 5.21

          • 47.82

          • Net Income

            5-Year Annual Average

          • 4.30

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 36.93

            • 42.70

            • Pre-Tax Margin

            • 14.44

            • 11.63

            • Net Profit Margin

            • 9.05

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 40.60

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 17.00

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.50

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.10

              • 0.62

              • Current Ratio

              • 2.11

              • 1.23

              • Quick Ratio

              • 1.77

              • 0.76

              • Interest Coverage

              • 9.41

              • 5.98

              • Leverage Ratio

              • 2.69

              • 2.16

              • Book Value/Share

              • 31.29

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 16.45

                • 33.22

                • P/E Ratio 5-Year High

                • 18.08

                • 325.07

                • P/E Ratio 5-Year Low

                • 11.39

                • 154.73

                • Price/Sales Ratio

                • 1.49

                • 2.34

                • Price/Book Value

                • 3.16

                • 3.04

                • Price/Cash Flow Ratio

                • 10.45

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 19.89

                    (23.70)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.70

                    (9.50)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 10.93

                    (11.40)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 15.56k

                  • 17.17k

                  • Inventory Turnover

                  • 28.27

                  • 5.07

                  • Asset Turnover

                  • 0.85

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  990.90M
                  Operating Margin
                  17.06
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  10.45
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  40.26%

                  Mutual Fund Ownership

                  51.97%

                  Float

                  88.41%

                  5% / Insider Ownership

                  0.78%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Davis New York Venture Fund

                  •  

                    3,535,370

                  • -25.72

                  • 4.16

                  • Perkins Mid Cap Value Fund

                  •  

                    1,494,471

                  • -14.76

                  • 1.76

                  • Vanguard Mid-Cap Index Fund

                  •  

                    1,452,465

                  • 1.21

                  • 1.71

                  • Harris Assoc. Equity & Income Strategy

                  •  

                    1,430,300

                  • 0.00

                  • 1.68

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,381,467

                  • 0.41

                  • 1.63

                  • Oakmark Equity and Income Fund

                  •  

                    1,224,059

                  • -14.42

                  • 1.44

                  • Principal MidCap Fund

                  •  

                    1,123,905

                  • -0.81

                  • 1.32

                  • Veritas Global Focus Fund

                  •  

                    1,100,000

                  • 18.92

                  • 1.30

                  • Selected American Shares Fund

                  •  

                    976,900

                  • -26.38

                  • 1.15

                  • JHancock Disciplined Value Mid Cap Fund

                  •  

                    887,010

                  • 1.65

                  • 1.04

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Davis Selected Advisers

                  •  

                    6,747,256

                  • -29.99%

                  • 7.95

                  • Vanguard Group, Inc.

                  •  

                    6,082,882

                  • +1.13%

                  • 7.16

                  • State Street Corp

                  •  

                    3,756,399

                  • -14.19%

                  • 4.42

                  • Veritas Asset Management LLP

                  •  

                    3,634,485

                  • +6.41%

                  • 4.28

                  • Harris Associates L.P.

                  •  

                    3,162,206

                  • +0.45%

                  • 3.72

                  • Robeco Investment Management, Inc.

                  •  

                    3,015,081

                  • +223.22%

                  • 3.55

                  • BlackRock Fund Advisors

                  •  

                    2,631,242

                  • +0.06%

                  • 3.10

                  • Perkins Investment Management LLC.

                  •  

                    1,785,286

                  • -14.50%

                  • 2.10

                  • Principal Global Investors, LLC

                  •  

                    1,727,349

                  • -2.07%

                  • 2.03

                  • Pzena Investment Management, LLC

                  •  

                    1,654,529

                  • -26.69%

                  • 1.95

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Mid Value

                  Laboratory Corp of America Hldgs, founded in 1971, is an independent clinical laboratory company in the United States. Since the Companys founding, it has grown into a national network of 54 primary laboratories and over 1,700 patien...moret service centers along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately). Through its national network of laboratories, the Company offers a broad range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, the Company has developed testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic ...moregenetics and clinical trials. Laboratory tests and procedures are used generally by hospitals, physicians and other health care providers and commercial clients to assist in the diagnosis, evaluation, detection, therapy selection, monitoring and treatment of diseases and other medical conditions through the examination of substances in the blood, tissues and other specimens. The Company believes that it competes favorably with its principal competitors in each of these areas and is currently implementing strategies designed to improve its competitive position. The Companys strategic plan continues to focus on three critical priorities: scientific differentiation, managed care, and customer service. The Company offers its services through a sales force focused on serving the specific needs of customers in different market segments. These market segments generally include Specialty Cancer, Hospitals and Primary Care. The Company is subject to licensing and regulation under federal, state and local laws and regulations relating to the protection of the environment and human health and safety and laws and regulations relating to the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.lessless

                  Key People

                  Mr. David P. King

                  CEO/Chairman of the Board/Director/President

                  Glenn A. Eisenberg

                  Executive VP/CFO

                  Mr. Lance V. Berberian

                  Chief Information Officer/Senior VP

                  James T. Boyle,Jr

                  COO/Executive VP

                  Jean-Luc Belingard

                  Director

                  • Laboratory Corp of America Hldgs

                  • 358 South Main Street

                  • Burlington, NC 27215

                  • USA.Map

                  • Phone: +1 336 229-1127

                  • Fax: -

                  • labcorp.com

                  Incorporated

                  1971

                  Employees

                  34,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: